Optimisation of tablet: Formulation & optimisation of rosuvastatin tablet by complexation with cyclodextrin by spray drying method - Tapa blanda

Kapse (Yelam), Vidya Nitin

9786139834358: Optimisation of tablet: Formulation & optimisation of rosuvastatin tablet by complexation with cyclodextrin by spray drying method

Tapa blanda

ISBN 10: 613983435X ISBN 13: 9786139834358

Editorial: LAP LAMBERT Academic Publishing, 2018

Ver todas las copias de esta edici�n del ISBN

0 Usado

8 Nuevo

De EUR 49,90

Detalles de la edici�n

Editorial: LAP LAMBERT Academic Publishing
A�o de publicaci�n: 2018
Idioma: Ingl�s
ISBN 10: 613983435X
ISBN 13: 9786139834358
Encuadernaci�n: Tapa blanda
N�mero de p�ginas: 100
Contacto del fabricante: no disponible
Persona responsable: no disponible

Resultados de la b�squeda para Optimisation of tablet: Formulation & optimisation...

Imagen del vendedor

Optimisation of tablet

Vidya Nitin Kapse (Yelam)

Publicado por LAP LAMBERT Academic Publishing Mai 2018, 2018

ISBN 10: 613983435X ISBN 13: 9786139834358

Nuevo Taschenbuch

Impresi�n bajo demanda

Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania

Calificaci�n del vendedor: 5 de 5 estrellas

Taschenbuch. Condici�n: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The most important property of a dosage form is its ability to deliver the active ingredients to the site of action in an amount sufficient to elicit the desired pharmacological response. This property of the dosage form has been variously referred to its physiological availability, biological availability or bioavailability. 'Bioavailability is defined more precisely as the rate and extent of absorption of a drug from its dosage form in to the systemic circulation'. Many of the new drugs (APIs) exhibits low and variable dissolution and bioavailability due to their poor aqueous solubility at physiological pHs and consequent low dissolution rate. These drugs are classified as class II drugs under BCS classification. Biopharmaceutical Classification System (BCS) guidance was provided by USFDA to improve the efficiency of drug product development process in the BCS, drugs are grouped into four major classes basing on the solubility and permeability as follows: I. Class I (High solubility and High permeability) II. Class II (Low solubility and High permeability) III. Class III (high solubility and low permeability) IV. Class IV (Low solubility and Low permeability). 100 pp. Englisch. N� de ref. del art�culo: 9786139834358

Contactar al vendedor

Comprar nuevo

EUR 49,90

Env�o por EUR 23,00
Se env�a de Alemania a Estados Unidos de America

Cantidad disponible: 2 disponibles

A�adir al carrito

Imagen de archivo

Optimisation of tablet

Kapse (Yelam), Vidya Nitin

ISBN 10: 613983435X ISBN 13: 9786139834358

Nuevo Tapa blanda

Librería: Books Puddle, New York, NY, Estados Unidos de America

Calificaci�n del vendedor: 4 de 5 estrellas

Condici�n: New. N� de ref. del art�culo: 26397279451

Contactar al vendedor

Comprar nuevo

EUR 80,27

Env�o por EUR 3,51
Se env�a dentro de Estados Unidos de America

Cantidad disponible: 4 disponibles

A�adir al carrito

Imagen de archivo

Optimisation of tablet

Kapse (Yelam), Vidya Nitin

ISBN 10: 613983435X ISBN 13: 9786139834358

Nuevo Tapa blanda

Impresi�n bajo demanda

Librería: Majestic Books, Hounslow, Reino Unido

Calificaci�n del vendedor: 4 de 5 estrellas

Condici�n: New. Print on Demand. N� de ref. del art�culo: 400146180

Contactar al vendedor

Comprar nuevo

EUR 81,52

Env�o por EUR 7,61
Se env�a de Reino Unido a Estados Unidos de America

Cantidad disponible: 4 disponibles

A�adir al carrito

Imagen del vendedor

Optimisation of tablet

Vidya Nitin Kapse (Yelam)

Publicado por LAP LAMBERT Academic Publishing, 2018

ISBN 10: 613983435X ISBN 13: 9786139834358

Nuevo Tapa blanda

Impresi�n bajo demanda

Librería: moluna, Greven, Alemania

Calificaci�n del vendedor: 5 de 5 estrellas

Condici�n: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Kapse (Yelam) Vidya NitinMrs. Vidya Nitin Kapse has completed her B.Pharm and M.Pharm (Pharmaceutics) from PDVVP College of Pharmacy, Ahmednagar, PUNE University. She has total 12 years of teaching experience at Shivlingeshwar Colleg. N� de ref. del art�culo: 385873399

Contactar al vendedor

Comprar nuevo

EUR 41,71

Env�o por EUR 48,99
Se env�a de Alemania a Estados Unidos de America

Cantidad disponible: M�s de 20 disponibles

A�adir al carrito

Imagen de archivo

Optimisation of tablet

Kapse (Yelam), Vidya Nitin

ISBN 10: 613983435X ISBN 13: 9786139834358

Nuevo Tapa blanda

Impresi�n bajo demanda

Librería: Biblios, Frankfurt am main, HESSE, Alemania

Calificaci�n del vendedor: 4 de 5 estrellas

Condici�n: New. PRINT ON DEMAND. N� de ref. del art�culo: 18397279441

Contactar al vendedor

Comprar nuevo

EUR 81,69

Env�o por EUR 9,95
Se env�a de Alemania a Estados Unidos de America

Cantidad disponible: 4 disponibles

A�adir al carrito

Imagen del vendedor

Optimisation of tablet

Vidya Nitin Kapse (Yelam)

Publicado por LAP LAMBERT Academic Publishing Mai 2018, 2018

ISBN 10: 613983435X ISBN 13: 9786139834358

Nuevo Taschenbuch

Impresi�n bajo demanda

Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania

Calificaci�n del vendedor: 5 de 5 estrellas

Taschenbuch. Condici�n: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The most important property of a dosage form is its ability to deliver the active ingredients to the site of action in an amount sufficient to elicit the desired pharmacological response. This property of the dosage form has been variously referred to its physiological availability, biological availability or bioavailability. �Bioavailability is defined more precisely as the rate and extent of absorption of a drug from its dosage form in to the systemic circulation�. Many of the new drugs (APIs) exhibits low and variable dissolution and bioavailability due to their poor aqueous solubility at physiological pHs and consequent low dissolution rate. These drugs are classified as class II drugs under BCS classification. Biopharmaceutical Classification System (BCS) guidance was provided by USFDA to improve the efficiency of drug product development process in the BCS, drugs are grouped into four major classes basing on the solubility and permeability as follows: I. Class I (High solubility and High permeability) II. Class II (Low solubility and High permeability) III. Class III (high solubility and low permeability) IV. Class IV (Low solubility and Low permeability).VDM Verlag, Dudweiler Landstra�e 99, 66123 Saarbr�cken 100 pp. Englisch. N� de ref. del art�culo: 9786139834358

Contactar al vendedor

Comprar nuevo

EUR 49,90

Env�o por EUR 60,00
Se env�a de Alemania a Estados Unidos de America

Cantidad disponible: 1 disponibles

A�adir al carrito

Imagen del vendedor

Optimisation of tablet : Formulation & optimisation of rosuvastatin tablet by complexation with cyclodextrin by spray drying method

Vidya Nitin Kapse (Yelam)

Publicado por LAP LAMBERT Academic Publishing

ISBN 10: 613983435X ISBN 13: 9786139834358

Nuevo Taschenbuch

Impresi�n bajo demanda

Librería: AHA-BUCH GmbH, Einbeck, Alemania

Calificaci�n del vendedor: 5 de 5 estrellas

Taschenbuch. Condici�n: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The most important property of a dosage form is its ability to deliver the active ingredients to the site of action in an amount sufficient to elicit the desired pharmacological response. This property of the dosage form has been variously referred to its physiological availability, biological availability or bioavailability. 'Bioavailability is defined more precisely as the rate and extent of absorption of a drug from its dosage form in to the systemic circulation'. Many of the new drugs (APIs) exhibits low and variable dissolution and bioavailability due to their poor aqueous solubility at physiological pHs and consequent low dissolution rate. These drugs are classified as class II drugs under BCS classification. Biopharmaceutical Classification System (BCS) guidance was provided by USFDA to improve the efficiency of drug product development process in the BCS, drugs are grouped into four major classes basing on the solubility and permeability as follows: I. Class I (High solubility and High permeability) II. Class II (Low solubility and High permeability) III. Class III (high solubility and low permeability) IV. Class IV (Low solubility and Low permeability). N� de ref. del art�culo: 9786139834358

Contactar al vendedor